Will LNG Exports Work in the Long Term?

There is an immense opportunity in the global LNG market because of huge arbitrage opportunity in natural gas prices in various locations around the world. One example is the price difference between the U.S. and Europe, where Henry Hub spot prices are almost $10 below spot prices in Europe. Although this does present a huge opportunity, the competition for LNG exports worldwide is about to get much stiffer. 

According to Wolfgang Moehler at IHS, global demand for LNG will grow to around 60 million to 80 million tons per year by 2020. While this may seem like a big market to fill, it's much smaller than the total capacity of proposed LNG export facilities. Proposed facilities in the U.S. alone far outpace anticipated global demand, and other LNG export regions such as Australia, sub-Saharan Africa, and Canada all want a piece of the pie as well. 

5 Best Casino Stocks To Buy Right Now

Still, there are a few advantages the U.S. has in the race to capture LNG market share. We are the only country that is producing shale gas in commercial amounts, and a few companies have already started construction on export terminals. Cheniere Energy (NYSEMKT: LNG  ) will become the first LNG exporter approved to ship to countries that aren't members of a free trade agreement. With contracts for its first two LNG trains locked in for the next 20 years, Cheniere is primed for solid gains once the initial LNG trains start chugging in the first half of 2015. Be sure to read all the details in this premium research report.

In the following video, Fool.com contributor Tyler Crowe joins Joel South and Taylor Muckerman in the studio to discuss some of the emerging trends in the LNG export game both in the U.S. and abroad.

One home-run investing opportunity has been slipping under Wall Street's radar for months. But it won't stay hidden much longer. Forward-thinking energy players such as General Electric and Ford have already plowed sizable amounts of research capital into this little-known stock, because they know it holds the key to the explosive profit power of the coming "no choice fuel revolution." Luckily, there's still time for you to get on board if you act quickly. All the details are inside an exclusive report from The Motley Fool. Click here for the full story!

Boeing's Fireproof Stock

The following video is from Monday's Investor Beat, in which host Chris Hill, and analysts Jason Moser and Matt Koppenheffer, dissect the hardest-hitting investing stories of the day.

Shares of Boeing fell by 5% last Friday on news that an empty 787 Dreamliner caught fire on a London Heathrow runway; the stock has since rebounded, after it was announced that the battery was not the cause of the fire. In this video, Jason and Matt discuss how much more headline trouble Boeing can endure before it's stock takes a serious hit, and whether or not it looks like an attractive buy today.

Also, a look at Citigroup's incredible year, a major leap for Leap Wireless after AT&T offers a buyout at a very nice premium, why BlackBerry's latest price cut may be desperation, and Fairway Market's stellar performance since its IPO in April. Plus, two stocks that our analysts will be watching closely this coming week.

Top 10 Growth Stocks To Invest In 2014

The best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report, "3 Stocks That Will Help You Retire Rich," names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.

Will Nervous Fed-Watchers Crash the Dow Again?

Best Blue Chip Companies To Buy For 2014

A Fool Looks Back

Hulu, you're such a tease.

Once again, a bidding war for the streaming video service gets called off by the owner. Hulu's bigwig studio partners announced on Friday that they'll be keeping Hulu, putting an end to yet another lame auction process.

DIRECTV (NASDAQ: DTV  ) seemed like a shoo-in to win the Hulu sweepstakes. The country's largest satellite television provider doesn't have much of an online presence, and snapping up Hulu and potentially making it exclusive to DIRECTV subscribers could've really helped justify the pay-TV provider's hefty monthly rates.

Hulu's consortium of present owners are committing to invest $750 million to take the site to the next level. Hulu is popular for its ability to stream television shows between a day to a week after they initially air, but Hulu could use a page out of the faster-growing digital smorgasbords and beef up its catalog.

We'll see how far $750 million goes, and then we'll see who falls for the inevitable auction process for Hulu.

Briefly in the news
And now let's take a quick look at some of the other stories that shaped our week.

The future of smartphones may be a battle of megapixels. Nokia (NYSE: NOK  ) formally unveiled the Lumia 1020, a Windows Phone making waves for its 41-megapixel lens. The sky's the limit for priceline.com (NASDAQ: PCLN  ) . Morgan Stanley analyst Scott Devitt upgraded the fast-growing travel website operator, boosting his price target to $1,010. It's the first analyst to cross the four figures in setting a goal for Priceline. Tesla Motors (NASDAQ: TSLA  ) was tapped to fill next week's vacancy in the Nasdaq 100. The electric-car maker has tripled in recent months, making it one of the 100 largest non-financial stocks in the exchange.

5 Best Stocks To Watch For 2014

Beyond next week
Tax increases that took effect at the beginning of 2013 affected nearly every American taxpayer. But with the right planning, you can take steps to take control of your taxes and potentially even lower your tax bill. In our brand-new special report "How You Can Fight Back Against Higher Taxes," The Motley Fool's tax experts run through what to watch out for in doing your tax planning this year. With its concrete advice on how to cut taxes for decades to come, you won't want to miss out. Click here to get your copy today -- it's absolutely free.

This Week's Top 3 Stocks

In a week filled with earnings it would be easy to think that the market would move dramatically higher or lower. But at the end of the week, U.S. stock markets barely budged. with the Dow Jones Industrial Average (DJINDICES: ^DJI  ) gaining a paltry 0.10% and the S&P 500 (SNPINDEX: ^GSPC  ) up 0.45%. There wasn't a plethora of economic news, but a reading that consumers were more confident than they've been in six years should give everyone a little more hope that the economy is on a road to recovery.

Hewlett-Packard (NYSE: HPQ  ) was the biggest winner in the Dow this week, gaining 3.4%, but it may not have anything to do with HP at all. Competitor Dell's buyout ran into a snag this week, and the company's shareholder meeting was never actually concluded with a vote on Dell's offer. The longer this fiasco drags out, the less attention Dell's management can put into its PC business, and that's good for HP. It's amazing how fast the industry can flip, because just a few years ago, Dell looked like it had the rock-solid management and HP was being led by the blind. Today, the tables have turned, and we don't even know who's going to own Dell a few months from now.  

The big positive earnings move came from United Technologies (NYSE: UTX  ) , which jumped 2.4% after reporting a 15% increase in revenue to $16 billion. Full-year guidance was also moved higher as demand for aircraft components has driven the company's revenue. It looks like the acquisition of Goodrich last year was well timed, and while this stock won't hit our hot list very often, it's steady as they come and pays a solid 2.1% dividend yield.

Verizon (NYSE: VZ  ) rounds out the top three with a 2.1% gain, after Vodafone Group Chairman Gerard Kleisterlee said the company would consider a buyout of its stake in Verizon Wireless. Vodafone owns 45% of Verizon Wireless, and both companies have talked about a Verizon buyout for years with little luck. The problem at this point is price, and Vodafone may command $120 billion or more for its stake. Verizon would love to make the buyout, and make it while interest rates are low enough to borrow tens of billions of dollars for the deal, but it hasn't appeared willing to pay more than $100 billion. Still, the stock will move higher on just the prospect of seeing Verizon own all of Verizon Wireless, which is still the best asset in wireless right now.

Top stocks for long-term investors
If you're an investor who prefers returns to rhetoric, you'll want to read The Motley Fool's new free report "5 Dividend Myths ... Busted!" In it, you'll learn which stocks provide premium growth and whether bigger dividends are better. Click here to keep reading.

Top 5 Casino Companies To Buy Right Now

Can you name the gambling capital of the world? 

If your answer is "Las Vegas," you're wrong. 

Macau is the world's leading destination for betting, having passed Vegas back in 2006 in terms of gambling revenue. 

This 11-square-mile special administrative region of China is a self-governed casino destination along China's southern coast. Last year, gambling accounted for 50% of Macau's GDP and 84% of its fiscal revenues.

So what's the best way to play this intriguing and rapidly growing market? 

Melco Crown Entertainment (Nasdaq: MPEL) is the absolute best pure play on the Macau gaming market, generating 100% of its revenue from the region. 

Other major casino operators have a presence in Macau, including Las Vegas Sands (NYSE: LVS), MGM Resorts (NYSE: MGM) and Wynn Resorts (Nasdaq: WYNN), but their revenues are diluted by their exposure to Las Vegas and other U.S. markets. Vegas Sands gets 52% of EBITDA (earnings before interest, taxes, depreciation and amortization) from Macau, while MGM receives 33% and Wynn earns 74%. 

Top 5 Casino Companies To Buy Right Now: Penn National Gaming Inc.(PENN)

Penn National Gaming, Inc. and its subsidiaries own and manage gaming and pari-mutuel properties in the United States. It operates approximately 27,000 gaming machines; 500 table games; and 2,000 hotel rooms in 23 facilities in 16 jurisdictions, including Colorado, Florida, Illinois, Indiana, Iowa, Louisiana, Maine, Maryland, Mississippi, Missouri, New Jersey, New Mexico, Ohio, Pennsylvania, West Virginia, and Ontario. The company was formerly known as PNRC Corp. and changed its name to Penn National Gaming, Inc. in 1994. Penn National Gaming, Inc. was founded in 1982 and is based in Wyomissing, Pennsylvania.

Advisors' Opinion:

• [By Quickel]

  Penn National Gaming(PENN) squeaked past its guidance through improved cost controls, and investors praised its efforts.

  But expectations were low, and its upbeat outlook shouldn't be viewed as a message that regional markets are recovering. "Going forward, we project soft regional gaming revenue results over the next three to six months, as we do not expect to see a significant increase in consumer spending patterns given the uncertain economic environment," J.P. Morgan analyst Joseph Greff wrote in a note.

  Penn National raised its full-year earnings guidance to $1.18 from $1.13 a share, and up its revenue outlook by $26 million to $2.44 billion from $2.41 billion.

  During the second quarter, the company earned $9.2 million, or 9 cents a share, compared with $28.5 million, or 27 cents, in the year-ago period. Excluding items, Penn actually earned 29 cents a share, a penny higher than estimates.

  Revenue rose 3% to $598.3 million, higher than the $597.1 million Wall Street projected. The upside was driven by both better revenues and margins and was generally broad-based across many properties, especially larger venues in Charlestown, Lawrenceburg and Grantville, Pa.

  Penn National rolled out table games in West Virginia and Pennsylvania during the quarter, which should be a growth catalyst moving forward. The company also plans to open a slot facility in Maryland on Sept. 30 and expects its Toldeo, Ohio, location to open in the first-half of 2012. Its Columbus project is slated to open in the second-half of 2012.

  The company repurchased 409,000 shares during the quarter. "[This] sends a message to investors on the value of its equity, but perhaps indicating the lack of near-term acquisition opportunities," J.P. Morgan analyst Joseph Greff wrote in a note.

Top 5 Casino Companies To Buy Right Now: Wynn Resorts Limited(WYNN)

Wynn Resorts, Limited, together with its subsidiaries, engages in the development, ownership, and operation of destination casino resorts. The company owns and operates Wynn Las Vegas casino resort in Las Vegas, which includes approximately 22 food and beverage outlets comprising 5 dining restaurants; 2 nightclubs; 1 spa and salon; 1 Ferrari and Maserati automobile dealership; wedding chapels; an 18-hole golf course; meeting space; and foot retail promenade featuring boutiques. Wynn Las Vegas casino resort also features approximately 147 table games, 1 baccarat salon, private VIP gaming rooms, 1 poker room, 1,842 slot machines, and 1 race and sports book. It also owns and operates an Encore at Wynn Las Vegas resort, a destination casino resort located adjacent to Wynn Las Vegas that features a 2,034 all-suite hotel, as well as a casino with 95 table games, 1 sky casino, 1 baccarat salon, private VIP gaming rooms, and 778 slot machines. In addition, the company operates Wyn n Macau casino resort located in the Macau Special Administrative Region of the People?s Republic of China. Wynn Macau casino resort features approximately 595 hotel rooms and suites, 410 table games, 935 slot machines, 1 poker room, 1 sky casino, 6 restaurants, 1 spa and salon, lounges, meeting facilities, and retail space featuring boutiques. Further, it operates Encore at Wynn Macau resort located adjacent to Wynn Macau. Encore at Wynn Macau resort features approximately 410 luxury suites and 4 villas, as well as casino gaming space, including a sky casino consisting of 60 table games and 80 slot machines, 2 restaurants, 1 luxury spa, and retail space. The company was founded in 2002 and is based in Las Vegas, Nevada.

Advisors' Opinion:

• [By Carlson]

  Wynn Resorts(WYNN) saw its second-quarter profit more than double, but most of that strength came from casino wins, and investors were unimpressed.

  During the quarter, the casino operator earned $52. 4 million, or 52 cents a share, on revenue of $1.03 billion, higher than forecasts of 42 cents on revenue of $992.3 million. This compares with a profit of $25.5 million, or 21 cents, on revenue of $723.3 million, in the year-ago period.

  Wynn had already pre-announced disappointing results for its Las Vegas properties, citing higher costs, including employee health care and benefits, and marketing expenses. Its operating loss for its Wynn Las Vegas and Encore widened to $17.2 million from $8.3 million last year. Revenue rose 1.7% to $318 million.

  Occupancy at the Wynn Las Vegas jumped to 92.6% from 86.6% a year earlier, but revenue per available room fell 3.2%.

  Still, management indicated that there is a slight improvement on the Strip, with an increase in forward group bookings and some bright spots for the ability to yield rates. But management tempered enthusiasm by saying there are some struggles and uncertainty in the marketplace.

  "We hope for continued improvement in Las Vegas or -- let me put it different, we hope that we'll get smarter in Las Vegas in dealing with the peculiarities of this market --and this very, very mercurial, national economic market we're living with," said Steve Wynn, chief executive, in a conference call. "The national economy and the political environment in the country as we head up to the elections [is] very, very touchy. And it is impacting all businesses."

  The biggest boost, of course, came from Macau, where revenue surged 74% to $714.4 million from $410.4 million last year.

  The company opened its Encore Macau in the spring, boosting its market share to about 16% from about 13%, Sterne Agee analyst David Bain wrote in a note.

  Wynn is in the process of working on a new development on the Cotai st! rip, which should spike investors' interest as more details are revealed in the coming quarters.

  Still, investors are concerned that as comparisons get harder in Macau, and second-quarter results are adjusted for hold (how much the casino won), Wynn may not be able to outperform. But Bain reassures, "this has been discussed as nauseam by investors, sell-side analysts, the press -- and even dinner-table relatives -- for some time. We believe the Street is underestimating the summer months in Macua, which may help to produce a new leg up for Macau stories, with Wynn being the most profitable on a per position basis."

Top Stocks To Own For 2014: Boyd Gaming Corporation(BYD)

Boyd Gaming Corporation, together with its subsidiaries, operates as a multi-jurisdictional gaming company in the United States. As of December 31, 2011, the company owned and operated 1,042,787 square feet of casino space, containing approximately 25,973 slot machines, 655 table games, and 11,418 hotel rooms. It also owned and operated 16 gaming entertainment properties located in Nevada, Illinois, Louisiana, Mississippi, Indiana, and New Jersey. In addition, the company owns and operates a pari-mutuel jai-alai facility located in Dania Beach, Florida, as well as a travel agency in Hawaii. Further, it holds a 50% controlling interest in the limited liability company that operates Borgata Hotel Casino and Spa in Atlantic City, New Jersey. Boyd Gaming Corporation was founded in 1988 and is headquartered in Las Vegas, Nevada.

Advisors' Opinion:

• [By Hesler]

  Boyd Gaming(BYD) posted a bigger-than-expected drop in its second-quarter earnings, citing weak performance in Las Vegas, the Midwest and the South.

  During the quarter, the casino operator earned $3.4 million, or 4 cents a share, a 73% plunge from $12.8 million, or 15 cents, in the year-ago period. Adjusted earnings came in at 5 cents a share, significantly lower than the 10 cents Wall Street predicted for Boyd.

  Boyd's revenue fell 6% to $578.4 million, also short of the consensus of $588 million.

  "The lingering effects of the recession have left consumers unusually sensitive to shifts in the economy, and they now react more quickly to economic data and other developments, such as fluctuations in the stock market," said CEO Keith Smith, in a statement. "Although conditions remain uncertain, we believe long-term stabilizing trends are still in place, and that year-over-year growth is achievable by the end of 2010."

  In the Las Vegas locals market, the rate of decline in earnings before interest, taxes, depreciation and amortization rose to 16.2% from 10.8%, J.P. Morgan analyst Joseph Greff wrote in a note. Boyd previously reported a 9.9% decline for its Borgata property in Atlantic City. Revenue came in at $186.9 million, a 2.4% decrease from the year-ago period.

  "We think second-quarter results are less important than the coming operating results in the second-half of 2010, when the Atlantic City market faces increased regional competitive pressures from tables in Pennsylvania and West Virginia and the first Philadelphia casino opens this summer," J.P. Morgan analyst Joseph Greff wrote in a note.

  Greff reaffirmed his underweight rating on Boyd, given increasing competition in Atlantic City, a weak recovery in the Las Vegas locals market and stagnant regional gaming trends.

  While there is no doubt the Atlantic City gaming market remains one of the most depressed, Borgata continues to dominate the market and gain share. Atlant! ic City saw gaming revenues plunge 11.1% in June to $286.8 million. Boyd co-owns Borgata with MGM Resorts, which is currently in the process of divesting its 50% stake.

Top 5 Casino Companies To Buy Right Now: Pinnacle Entertainment Inc.(PNK)

Pinnacle Entertainment, Inc. owns, develops, and operates casinos, and related hospitality and entertainment facilities in the United States. It operates casinos, such as L'Auberge du Lac in Lake Charles, Louisiana; River City Casino and Lumiere Place in St. Louis, Missouri; Boomtown New Orleans in New Orleans, Louisiana; Belterra Casino Resort in Vevay, Indiana; Boomtown Bossier City in Bossier City, Louisiana; and Boomtown Reno in Reno, Nevada. The company also operates River Downs racetrack in southeast Cincinnati, Ohio. As of May 26, 2011, it operated seven casinos and one racetrack. The company was formerly known as Hollywood Park, Inc. and changed its name to Pinnacle Entertainment, Inc. in February 2000. Pinnacle Entertainment, Inc. was founded in 1935 and is based in Las Vegas, Nevada.

Advisors' Opinion:

• [By Jeanine Poggi]

  Pinnacle Entertainment(PNK) was the great transition story of 2010, with shares spiking about 45% this year.

  The regional casino operator's most impressive story has been in its gross margins, as management, under the leadership of new CEO Anthony Sanfilippo, is in the process of increasing the company's operating efficiencies and prudently allocating capital. Analysts believe Pinnacle is in the early stages of this process, and will continue to drive revenue growth.

  In its third quarter, Pinnacle reported a surprise profit of 10 cents a share on an adjusted basis, better than consensus estimates of a loss of 7 cents. Revenue grew 15% to $287.8 million, while property-level margins reached 23.4%, also ahead of forecasts.

  Last month, Pinnacle purchased Cincinnati's River Downs Racetrack for $45 million. The deal includes 155 acres, 35 of which are still undeveloped. The transaction is expected to close by the end of the first quarter of 2011.

  This deal could generate significant returns in the event that Ohio decides to legalize video lottery terminals at racetracks, Santarelli said.

  Pinnacle is also in the process of looking for a buyer of its oceanfront land in Atlantic City, where it originally intended to build a $1.5 billion casino, before squelching plans. The casino operator bought the land in 2006 for $270 million from groups affiliated with Carl Icahn and later added another piece of land for $70 million.

  While the land's currently value is $38 million, Pinnacle insists it will not sell it on the cheap, holding out for the best deal.

  Pinnacle currently has $228 million in cash and $375 million of availability under its revolver.

Top 5 Casino Companies To Buy Right Now: (XTRN)

Las Vegas Railway Express Inc. focuses to re-establish a conventional passenger train service between the Las Vegas and Los Angeles metropolitan areas. It plans to establish a ?Vegas-style? passenger train service. The company is based in Las Vegas, Nevada.

FDA Delays Decision (i.e., Reverts to Norm)

10 Best High Tech Stocks To Own For 2014

LONDON -- The�FTSE 100�has been hovering around yesterday's levels all morning, rising to set a new five-year record of 6,593 points at midday, to then fall back to 6,583 points as I write -- bang on its previous close. Although strong company earnings have pushed up the index of top U.K. shares in recent days, there have been a few weaker updates that are holding it back a little today.

Which shares are not doing so well? Here are three from the various indexes that are dropping today:

Wm. Morrison
Shares in�Wm. Morrison Supermarkets�dipped 7.7 pence (2.6%) to 288 pence, after the firm reported a drop in performance in its first quarter. For the 13 weeks to 5 May, total sales excluding fuel fell by 0.6%, with like-for-like sales down 1.8%. Shareholders will also, presumably, be disappointed by the ongoing absence of�online shopping at Morrisons, though chief executive Dalton Phillips did say, "Strategically, our ambition of building a genuinely multi-format, multi-channel Morrisons is right on track".

10 Best High Tech Stocks To Own For 2014: Scantech Ltd(SCD.AX)

Scantech Limited, through its subsidiaries, manufactures and markets scientific and industrial instruments for resource sector, including cement, coal, and minerals industries in Australia and internationally. It also offers consulting services to the coal industry and in-field support of scientific and industrial instruments. The company?s products include GEOSCAN?M, a real time elemental analyzer, for a range of industries, including iron, copper, phosphate, nickel, manganese, bauxite, and zinc. It also provides IRONSCAN and Model 1500 Natural Gamma Minerals Monitor, which is used for dilution monitoring, mine optimization, plant process control, uranium ore grade monitoring and control, and mineral sand grade monitoring; COALSCAN, a real time coal quality analyzer used for automated blending, sorting, washery optimization, loadout quality control, and moisture for coal production market, as well as for stockpile management, contract surveillance, automated blending, b unker-feed monitoring, and moisture applications for power generation sector. In addition, the company offers GEOSCAN-C for mine feedback and control, limestone sorting, stockpile building, and raw mix proportioning in cement manufacturing; CIFA for carbon in fly ash monitoring; and CM100 Moisture Monitor for use in moisture monitoring of coke and sinter feed for blast furnaces in steel production. Further, it provides TBM 200 Series Microwave Moisture Monitor for use in moisture monitoring, dust management, filter and dryer control, tonnage correction, and metal accounting. Additionally, the company offers a range of technical services, including installation support, commissioning, calibration, and maintenance of real time analyzers, as well as provides spare parts. Scantech Limited was founded in 1981 and is headquartered in Camden Park, Australia.

10 Best High Tech Stocks To Own For 2014: British American Tobacco Industries p.l.c.(BTI)

British American Tobacco p.l.c., through its subsidiaries, engages in the manufacture, distribution, and sale of tobacco products. The company offers cigars, cigarettes, smokeless snus, roll-your-own, and pipe tobacco products under the Dunhill, Kent, Lucky Strike, Pall Mall, Vogue, Viceroy, Kool, Rothmans, Peter Stuyvesant, Benson & Hedges, and State Express 555 brand names. It has operations in the Asia-Pacific, the Americas, eastern and western Europe, Africa, and the Middle East. The company was founded in 1902 and is headquartered in London, the United Kingdom. British American Tobacco p.l.c. operates independently of Remgro Ltd. as of November 03, 2008.

Best Stocks For 2014: Amplifon Spa(AMP.MI)

Amplifon SpA engages in the distribution, fitting, and personalization of hearing aids and related products, and connected services designed for hearing disabilities worldwide. It offers various hearing systems/aids, batteries, consumables, repairs, accessories, spare parts and services, and biomedical products. The company distributes its products through direct points of sale; and indirect points of sale, such as franchisees and wholesale channels. Amplifon SpA operates approximately 3,200 specialist stores, 1,600 affiliated shops, and 2,200 authorized centers. The company was founded in 1950 and is headquartered in Milan, Italy. Amplifon S.p.A. is a subsidiary of Ampliter N.V.

10 Best High Tech Stocks To Own For 2014: Hawaiian Holdings Inc.(HA)

Hawaiian Holdings, Inc., through its subsidiary, Hawaiian Airlines, Inc., engages in the scheduled air transportation of passengers and cargo. It offers daily service on transpacific routes between Hawaii and Los Angeles, Oakland, Sacramento, San Diego, San Francisco, and San Jose, California; Las Vegas, Nevada; Phoenix, Arizona; Portland, Oregon; and Seattle, Washington, as well as daily service on its inter island routes among the four islands of the State of Hawaii. The company also provides scheduled service on its Pacific routes between Hawaii and Pago Pago, American Samoa; Papeete, Tahiti; Sydney, Australia; Manila, Philippines; Tokyo, Japan; and Seoul, South Korea, as well as other ad hoc charters. As of December 31, 2010, its fleet consisted of 15 Boeing 717-200 aircraft for its interisland routes; 18 Boeing 767-300; and 3 Airbus A330-200 aircrafts for its transpacific, Pacific, and charter routes. Hawaiian Holdings, Inc. was founded in 1929 and is headquartered in Honolulu, Hawaii.

10 Best High Tech Stocks To Own For 2014: Taiwan Semiconductor Manufacturing Co Ltd (TSM)

Taiwan Semiconductor Manufacturing Co., Ltd. is a Taiwan-based company principally engaged in the research, development, manufacture and distribution of integrated circuit (IC) related products. The Company operates its businesses through wafer manufacture, mask production, wafer testing and packaging components. The Company also involves in the provision of production management, customer services and design services. Its products and services are applied in the manufacture of personal computers and peripheral products, information related products, wire and wireless communication systems, automobile and industrial equipment, as well as consumer electronic products, such as digital disk players, digital televisions (TVs), game consoles, digital cameras, among others. Its customers include Altera, AMD, Broadcom, Marvell, NVIDIA, Qualcomm, Analog Devices, Freescale, NXP and Texas Instruments, among others. In July 2010, Taiwan Semiconductor Manufacturing Co. acquired mechanical and engineering equipment from ASML HONG KONG LTD. In September 2010, the Company acquired a set of equipments from ASML HONG KONG LTD. In December 2010, the Company acquired a set of equipment from TOKYO ELECTRON LTD., KLA-TENCOR CORP. and NOVELLUS SYSTEMS INTERNATIONAL,B.V. In January 2011, the Company announced that it had acquired a set of equipment from KLA-TENCOR CORP., a set of equipment and facility, and another set of equipment from VARIAN SEMI. EQUIP. ASSOCIATES GmbH. In March 2011, the Company acquired a set of equipments from Rudolph Technologies, Inc.In March 2011, the Company acquired a set of equipments from Rudolph Technologies, Inc. In May 2011, it acquired a set of equipments form APPLIED MATERIALS SOUTH EAST ASIA PACIFIC LTD., Hamatech APE Gmbh and CO. KG, TOKYO ELECTRON LTD., DAINIPPON SCREEN MFG. CO., LTD., and VARIAN SEMI. EQUIP. ASSOCIATES GMBH.

TSMC's customers include semiconductor companies, ranging from fabless semiconductor and systems companies, such as Advanced Micro Devices, In! c., Altera Corporation, Broadcom Corporation, Marvell Semiconductor Inc., MediaTek Inc., nVidia Corporation and Qualcomm Incorporated, to integrated device manufacturers, such as LSI Corporation, STMicroelectronics and Texas Instruments Inc. Fabless semiconductor and system companies accounted for approximately 80%, and integrated device manufacturers accounted for approximately 20% of its net sales as of December 31, 2009.

The Company manufactures semiconductors using CMOS and BiCMOS processes. The BiCMOS process combines the speed of the bipolar circuitry and the power consumption and density of the CMOS circuitry. It uses the CMOS process to manufacture logic semiconductors, memory semiconductors, including static random access memory (SRAM), flash memory, mixed-signal/ radio frequency (RF) semiconductors, which combine analog and digital circuitry in a single semiconductor, micro-electro-mechanical-system (MEMS), which combines micrometer featured mechanical parts, analog and digital circuitry in a single semiconductor, and embedded memory semiconductors, which combine logic and memory in a single semiconductor. The BiCMOS process is used to make high-end mixed-signal and other types of semiconductors.

10 Best High Tech Stocks To Own For 2014: MONEYSUPERMARKET.COM GROUP PLC ORD GBP0.02(WI)

Moneysupermarket.com Group PLC, together with its subsidiaries, provides online price comparison services in the United Kingdom. The company, through its Web sites moneysupermarket.com and travelsupermarket.com, provides online services to compare various products in the money, insurance, travel, and home services markets. It offers comparison services for financial products, including loans, credit cards, current accounts, mortgages, debt solutions, savings accounts, and business finance; insurance products, such as home insurance, life insurance, medical and motor insurance, breakdown cover, mortgage payment protection, payment protection, and pet and travel insurance; travel products comprising airport parking, car hire, flights, hotels, and package holidays; and home services products consisting of products for broadband, mobile telephones, vouchers, shopping, and utilities. The company also offers support services to customers to research the product they wish to purc hase, as well as sends emails to customers, enabling them to keep up to date with the latest deals, offers, and best buys on a range of products. The company was founded in 1993 and is based in Chester, the United Kingdom.

10 Best High Tech Stocks To Own For 2014: Convio Inc.(CNVO)

Convio, Inc. provides on-demand constituent engagement solutions that enable nonprofit organizations (NPOs) to raise funds, advocate for change, and cultivate relationships with donors, activists, volunteers, alumni, and other constituents in North America. Its integrated solutions include Convio Online Marketing (COM) platform, and Convio Common Ground CRM, a constituent relationship management application. The COM platform enables NPOs to harness the potential of the Internet and social media as new channels for constituent engagement and fundraising. The Common Ground delivers next-generation donor management capabilities, and integrates marketing activities across online and offline channels. The company also offers Convio Open, an open platform that allows NPOs to evolve their online marketing strategies; and Convio Go!, a structured program consisting of selected COM modules and specialized cohort-based services designed for mid-market NPOs new to online marketing an d fundraising. Convio, Inc.?s software enables its clients and partners to customize and extend its functionality. In addition, it provides account management, technical support, and deployment services, as well as strategic planning, campaign management, Web design, data analytics, benchmarking, campaign analytics, data integration, training, data warehousing, business intelligence, analytics/modeling, strategic consultation, and marketing execution services. The company sells its solutions through a direct sales force, as well as through a network of partners, including interactive agencies, direct marketing agencies, public affairs firms, and complementary technology companies. Convio, Inc. serves approximately 1,400 NPO clients, including charities. The company?s clients deliver approximately 4 billion emails to 140 million email addresses to accomplish their missions. Convio, Inc. was founded in 1999 and is headquartered in Austin, Texas.

10 Best High Tech Stocks To Own For 2014: Caribou Coffee Company Inc.(CBOU)

Caribou Coffee Company, Inc. owns and operates coffeehouses. The company offers premium coffee and espresso-based beverages, as well as specialty teas, handcrafted beverages, foods, coffee lifestyle items, branded merchandise, and related products. It also sells whole bean and ground coffee to grocery stores, mass merchandisers, office coffee providers, airlines, hotels, sports and entertainment venues, college campuses, and online customers. In addition, the company sells blended coffees and licenses its Caribou Coffee brand to Keurig, Inc. for sale and use in its K-Cup single serve line of business. Further, Caribou Coffee Company franchises its brand to partners to operate Caribou Coffee branded kiosks and coffeehouses, as well as sells Caribou Coffee branded products to partners for resale in these franchised locations. As of July 3, 2011, it operated 407 company-owned coffeehouses located in 16 states and the District of Columbia; and 147 franchised coffeehouses in th e United States and international markets. The company was founded in 1992 and is based in Brooklyn Center, Minnesota.

Advisors' Opinion:

• [By Roberto Pedone]

  One stock in the restaurant complex that has started to break out is Caribou Coffee(CBOU_). This company is engaged in operating coffeehouse in the U.S. The stock is off to a hot start in 2011, with shares up by over 35%.

  If you look at the chart for Caribou Coffee, you'll notice that this stock was hammered by the sellers from its August high of $17.40 to a recent low of $10.32 a share. Since marking that low, the stock has spiked big and now trades at just over $14 a share. What's even more noteworthy is that now the stock is starting to break out above some past overhead resistance at around $13.50 and above its 50-day moving average of $13.32 a share. This should easily set the stock up to make a run at its next significant r esistance level of $15 a share, or possibly much higher.

  If you're bullish on this stock, you could simply get long on off any noticeable weakness. I would place a stop just below $13.50 a share in case this breakout fails. I would add to this position only if the stock takes out $15 a share with heavy volume. Look for volume that's tracking in close to or above its three-month average action of 672,400 shares.

  This stock has a decent short interest -- around 6% of the tradable float is currently sold short by the bears. Caribou only has 18.35 million shares in its float, so this breakout could easily spark a massive short squeeze in the coming days or weeks. Keep this name on your trading radar.

  Caribou is one of TheStreet Ratings' top-rated restaurant and hotel stocks.

• [By James K. Glassman]

  Bridgeway Ultra-Small Company is a superb fund (it has an annualized return of 13.4% over the past ten years) that is closed to new investors. But we can still poach ideas from its portfolio. One of the best is Caribou Coffee (CBOU), a Starbucks competitor (with a better product, in this coffee drinker's opinion) whose sales have held up well. Analysts, on average, forecast that the company, which has nearly 500 stores, will boost its earnings by 30% in 2011. And the company has no debt.

10 Best High Tech Stocks To Own For 2014: Exoma Energy Ltd (EXE.AX)

Exoma Energy Limited engages in the exploration of oil and gas properties in Australia. The company explores for conventional oil, shale oil, and gas and coal seam gas contained in coal and carbonaceous shales. Exoma Energy Limited holds a 50% interest in 5 exploration permits covering an area of approximately 27,000 square kilometers of the Eromanga and Galilee Basins in Central Queensland. The company is headquartered in Brisbane, Australia.

10 Best High Tech Stocks To Own For 2014: Terex Corporation(TEX)

Terex Corporation manufactures capital goods machinery products worldwide. Its Aerial Work Platforms segment offers portable material lifts, portable aerial work platforms, trailer-mounted articulating booms and light towers, self-propelled articulating and telescopic booms, scissor lifts, telehandlers, and bridge inspection and utility equipment under the Terex and Genie brands. The company?s Construction segment provides off-highway trucks and material handlers; loader backhoes, compaction equipment, mini and midi excavators, site dumpers, compact track loaders, skid steer loaders, wheel loaders, and tunneling equipment; and asphalt and concrete equipment, and landfill compactors principally under the Terex name. Its Cranes segment offers mobile telescopic and tower cranes, lattice boom crawler and truck cranes, and truck-mounted cranes; and straddle and sprinter carriers, gantry cranes, ship-to-shore cranes, reach stackers, empty and full container handlers, and genera l cargo lift trucks under the Terex brand. The company?s Material Handling and Port Solutions segment provides standard and process cranes, rope and chain hoists, electric motors, and light crane systems; and crane components and port equipment, such as mobile harbor and automated stacking cranes, and automated guided vehicles, as well as terminal automation technology, including software under the Demag and Gottwald names. Its Materials Processing segment offers crushers, washing systems, screens, apron feeders, chippers, and related components and replacement parts under the Terex and Powerscreen brands. The company provides financing solutions to assist customers in the rental, leasing, and acquisition of its products. It serves construction, infrastructure, quarrying, mining, manufacturing, shipping, transportation, refining, energy, and utility industries through dealers, rental companies, direct sales, and major accounts. The company was founded in 1925 and is based i n Westport, Connecticut.

Top Dividend Stocks To Own Right Now

Externally managed real estate investment trust Anworth Mortgage Asset (NYSE: ANH  ) announced yesterday that it is increasing the conversion rate on its�6.25% Series B cumulative convertible preferred stock from�3.8695�shares of its common stock to 3.9202 shares effective July 9.

The REIT said it had announced last month it would be paying a dividend�of $0.15 per share on its common stock, but in accordance with the terms of its preferred shares, if the annualized yield on that dividend exceeds�6.25%,�the conversion rate on the Series B preferred stock is adjusted. The formula used is set in the preferred stock's articles, and as a result of the dividend to be paid on July 29, the conversion rate will change.

The regular dividend payment equates to a $0.60-per-share annual dividend, yielding 12.8% based on the closing price of Anworth Mortgage Asset's stock on July 8.

Top Dividend Stocks To Own Right Now: Minaean International Corp. (MIB.V)

Minaean International Corp., through its subsidiaries, engages in the development, production, and sale of building framing systems in India, Canada, and the United States. It offers Modular Quik-Build systems for retail buildings, housing and accommodations, schools, health centers, army barracks and field buildings, vacation homes, and resort housings; and Vesta Quik-Build systems for disaster relief programs. The company also provides Artisan Quik-Build systems for single story family residential buildings to multi-family mass housing residential buildings, as well as for commercial and industrial buildings; and light gauged steel components. In addition, it manufactures and installs ATM Kiosks for banks; street furniture ranging from bus queue shelters to public urinals, site camps, and other temporary accommodations; and gas station outlets. The company was incorporated in 1998 and is based in Vancouver, Canada.

Top Dividend Stocks To Own Right Now: Zix Corporation(ZIXI)

Zix Corporation provides Internet-based applications in software as a service model that enables the use of secure email for sensitive information exchange primarily in the healthcare, financial services, insurance, and government sectors in the United States. It offers email encryption service, a secure messaging service, which allows an enterprise to use policy-driven rules to determine which emails should be sent securely to comply with regulations or policies. The company also provides a solution that analyzes and encrypts email communications. Its services offer users the ability to deliver encrypted email to any email user at any email address by using the ZixCorp Best Method of Delivery protocol that automatically determines the direct and appropriate means of delivery, based on the sender?s and recipient?s communications environment and preferences. Zix Corporation sells its services through a direct sales force, and a network of resellers and other distribution partners. The company was formerly known as ZixIt Corporation and changed its name to Zix Corporation in 2002. Zix Corporation was founded in 1983 and is headquartered in Dallas, Texas.

Advisors' Opinion:

• [By Fernandez]

  ZixCorp(NASDAQ: ZIXI) (as the company refers to itself) is a leading provider of easy-to-use-and-deploy email encryption and e-prescribing services that connect entities with their customers and partners to protect and deliver sensitive information in the healthcare, finance, insurance and government industries.

  ZixCorp’s hosted Email Encryption Service provides an easy and cost-effective way to ensure customer privacy and regulatory compliance for corporate email and its Pocketscript® e-prescribing service saves lives and saves money by automating the prescription process between payors, doctors, and pharmacies.

  Zix Corp and its largest competitor Allscripts (NASDAQ: MDRX) provide e-prescribing technologies, which have pending legislation in the House and Senate to provide financial incentives to promote the adoption of the technology.

  e-prescribing is basically when you go to a doctor and they use a little handheld PDA to enter your prescription information, and then send it off to the pharmacy of your choice without having to write anything out on paper.

  This is a quicker and more streamlined way of doing business and has the added affect of catching any potential allergic or drug interactions through the cross-referencing capabilities of the software that is used.

  Zix has been a company that I have been looking into for over a year, but their stock price and fundamentals did not synch up.

  I still have to do more diligence and determine whether or not Allscripts or Zix have a better product, and more than that, if doctors without financial incentives, will adopt the e-prescribing interface, even though in the long run, it would save them money.

  Because of the legislative mandates and Zix’s recent announcements with large insurance providers like Aetna (NYSE: AET) in New Jersey and Blue Cross and Blue Shield of Alabama, I believe that we are in the beginning stages of this technology taking off and being accepted at more and more docto! r’s offices and that it will become mainstream in no time at all.

  The email encryption part of Zix’s business is just another revenue stream that acts as a corollary to their e-prescribing business and right now, accounts for the vast majority of their revenue.

  Why I Like the Company: Technology that is being pushed by legislature and will likely become widely adopted in the years to come providing the company a broad spectrum of runway in terms of future revenue growth; Valuation that has come in line with the company’s fundamentals; Possible merger/takeover target for their IP and applications/customer base; Improving fundamentals, including cash flow positive quarter has company on the verge of solid profitability

Best Stocks To Buy Right Now: Novadx Ventures Corp. (NDX.V)

NovaDX Ventures Corp. is a principal investment firm. The firm prefers to make direct investments in projects. Within direct investments it invests in those projects whose assets are undervalued and which can be among the lowest cost producers of commodities or processors of feed stocks. The firm also makes equity investments in net smelter royalties. It seeks to invest in acquisition of production payments or net profit interests, purchase of debt, convertible equity, secured loans or guarantees, purchase of IPOs, and participates in reorganization, privatizations, mergers, and consolidations. NovaDX Ventures Corp. is based in Vancouver, British Colombia.

10 Best Low Price Stocks To Own Right Now

Almost two months ago, I singled out�Tile Shop Holdings� (NASDAQ: TTS  ) as one of�three great small-cap stocks�with which many investors might not be familiar. After all, the high-end stone and tile specialist still had a market capitalization under $800 million at the time, and only just went public late last year.

Even so, the underlying business had grown from a single store in Minnesota nearly 30 years ago to 68 locations in 22 states. Better yet, the company was generating enough cash at the time to fund its accelerating expansion with free cash flow to spare.

In addition, Tile Shop's business is able to offer consumers low prices without sacrificing margin thanks to its ability to source products directly from quarries around the world, thus eliminating the middleman. Tile Shop also benefits from manufacturing its own line of adhesives, grouts, and other products required for the installation of its wares.

10 Best Low Price Stocks To Own Right Now: Cache Exploration Inc (CAY.V)

Cache Exploration Inc. engages in the acquisition, exploration, and development of mineral properties, primarily rare-earth metals in Canada. It holds options to acquire 70 % interest in certain mineral claims in the Bluff Lake property located in the Quesnel trough area of British Columbia; 80 % interest in the Welsford rare earth property located in New Brunswick; and 80 % interest in two property claims, such as the Cross Hills and the Louil Hills rare earth properties located in Newfoundland. The company also has options to acquire 100% interest in the Inner Welsford property claims in southern New Brunswick; and 160 claims in the Long Lake property located in northern New Brunswick. Cache Exploration Inc. is based in Vancouver, Canada.

10 Best Low Price Stocks To Own Right Now: Shore Bancshares Inc(SHBI)

Shore Bancshares, Inc. operates as the holding company for The Centreville National Bank of Maryland; The Talbot Bank of Easton, Maryland; and The Felton Bank, which provide various commercial and consumer banking products and services in Maryland and Delaware. It offers various deposit products, including commercial checking, savings, money market, Christmas savings, individual retirement, and overnight investment sweep accounts; interest-bearing and non-interest-bearing demand deposits, as well as time deposits; and certificates of deposit. The company also provides commercial loans, including secured and unsecured loans, working capital loans, lines of credit, term loans, accounts receivable financing, real estate acquisition development, construction loans, and letters of credit; and individual loans comprising mortgage, home improvement, installment, and other personal loans; credit cards; personal lines of credit; automobile; and other consumer financing. In addition , it offers merchant credit card clearing services; direct deposit of payroll, Internet banking, and telephone banking services; safe deposit boxes; debit cards; and automatic teller machine (ATM) services. Further, the company provides nondeposit products, such as mutual funds and annuities, and discount brokerage services; and trust, asset management, and financial planning services. Additionally, it offers insurance products and services, which comprise property and casualty, life, marine, individual health, and long term care insurance, as well as pension and profit sharing plans and retirement plans to businesses and consumers. The company operates 19 full service branches and 22 ATMs in the Kent County, Queen Anne?s County, Caroline County, Talbot County, and Dorchester County in Maryland, as well as in Kent County, Delaware. Shore Bancshares, Inc. was founded in 1876 and is based in Easton, Maryland.

10 Best Stocks To Own Right Now: Findel Plc(FDL.L)

Findel plc operates as a multi channel retailer in the business-to-consumer and business-to-business marketplaces in the United Kingdom, Europe, and Asia. The company operates in five segments: Express Gifts, Kleeneze, Kitbag, Education Supplies, and Healthcare. The Express Gifts segment engages in direct mail order businesses in the U.K., offering online and via catalogue a range of home and leisure items, clothing, toys, and gifts. The Kleeneze supplies household, and health and beauty products to customers through a network of independent distributors in the U.K. and the Republic of Ireland. The Kitbag segment is involved in the retail of sports leisurewear and official football kits both through its own online operation, kitbag.com, as well as through various partnership relationships with football clubs and other sports organizations, managing a range of retail, online, and/or mail order channels. The Education Supplies segment offers product that support curriculum s ubjects to schools and other educational establishments. This segment also supplies furniture and audio visual equipment, as well as commodity products, such as stationery and janitorial materials through its printed catalogue and through various e-procurement solutions. The Healthcare segment provides outsourced integrated community equipment services to trusts and local authorities. This segment also supplies a range of rehabilitation and care equipment to the public and private sectors through its catalogue and Internet. The company was formerly known as Fine Art Developments Limited and changed its name to Findel plc in 2000. Findel plc was founded in 1955 and is based in Hyde, the United Kingdom.

10 Best Low Price Stocks To Own Right Now: Mitsubishi UFJ Financial Group Inc (MTU)

Mitsubishi UFJ Financial Group, Inc. (MUFJ), incorporated on April 2, 2001, is a holding company for The Bank of Tokyo-Mitsubishi UFJ, Ltd. (BTMU), Mitsubishi UFJ Trust and Banking Corporation (MUTB), Mitsubishi UFJ Securities Holdings Co., Ltd. (MUSHD), Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.( MUMSS), Mitsubishi UFJ NICOS Co., Ltd. (Mitsubishi UFJ NICOS) and other companies engaged in a range of financial businesses. Its services include commercial banking, trust banking, securities, credit cards, consumer finance, asset management, leasing and fields of financial services. In May 2010, the Company and Morgan Stanley formed two joint ventures in Japan by integrating our respective Japanese securities companies engaged in investment banking and securities businesses. The Company converted the wholesale and retail securities businesses conducted in Japan by the former MUS into one of the joint venture entities, which is named MUMSS. Morgan Stanley contributed the investment banking operations conducted in Japan by its formerly wholly owned subsidiary, Morgan Stanley Japan Securities Co., Ltd. (MSJS) into MUMSS and converted the sales and trading and capital markets businesses conducted in Japan by MSJS into a second joint venture entity called Morgan Stanley MUFG Securities, Co., Ltd.

Integrated Retail Banking Business Group

The Integrated Retail Banking Business Group covers all domestic retail businesses, including commercial banking, trust banking and securities businesses, and enables the Company to offer a range of banking products and services, including financial consulting services, to retail customers in Japan. This business group integrates the retail business of BTMU, MUTB and MUMSS, as well as retail product development, promotion and marketing in a single management structure. Many of its retail services are offered through its network of MUFG Plazas providing individual customers with access to its financial product offerings of integrated commercial b! anking, trust banking and securities services.

The Company offers a range of bank deposit products, including a non-interest-bearing deposit account that is redeemable on demand and intended for payment and settlement functions, and is insured without a maximum amount limitation. It also offers a variety of asset management and asset administration services to individuals, including savings instruments, such as current accounts, ordinary deposits, time deposits, deposits at notice and other deposit facilities. MUFJ also offers trust products, such as loan trusts and money trusts, and other investment products, such as investment trusts, performance-based money trusts and foreign currency deposits.

The Company creates portfolios by combining savings instruments and investment products. It also provide a range of asset management and asset administration products, as well as customized trust products for high-net-worth individuals, as well as advisory services relating to the purchase and disposal of real estate and effective land utilization, and testamentary trusts. The Company provides a varied line up of investment trust products allowing its customers to choose products according to their investment needs through BTMU, MUTB and MUMSS, as well as kabu.com Securities, which specializes in online financial services. In the fiscal year ended March 31, 2010, BTMU offered a total of five investment trusts. As of the end of March 2010, BTMU offered its clients a total of 73 investment trusts.

The Company offers securities, including publicly offered stocks, foreign and domestic investment trusts, Japanese government bonds, foreign bonds and various other products. The Company offers housing loans, card loans and other loans to individuals. With respect to housing loans, in addition to housing loans incorporating health insurance for seven major illnesses, BTMU began offering in June 2009 preferential interest rates under its Environmentally Friendly Support program ! to custom! ers who purchase environment-conscious houses (like houses with solar electric systems), which meet specific criteria in response to increasing public interest in environmental issues. In September 2009, BTMU launched housing loans with home mortgage insurance, which BTMU jointly developed with the Japan Housing Finance Agency, a governmental agency under the Japanese government�� economic stimulus measures, under which the agency indemnifies BTMU for losses from housing loans.

The Company offers products and services through a range of channels, including branches, automated teller machines (ATMs) (including convenience store ATMs shared by multiple banks), Mitsubishi-Tokyo UFJ Direct (telephone, Internet and mobile phone banking), the Video Counter and postal mail. It offers integrated financial services combining its banking, trust banking and securities services at MUFG Plazas. These Plazas provide retail customers with integrated and flexible suite of services at one-stop outlets. As of March 31 2010, the Company provided those services through 47 MUFG Plazas. The Company offers MUTB�� trust related products and advisory services through its trust agency system not only for MUTB customers but also for BTMU and MUMSS customers. As of March 31, 2010, BTMU engaged in eight businesses as the trust banking agent for MUTB: testamentary trusts, inheritance management, asset succession planning, inheritance management agency operations, business management financial consulting, lifetime gift trusts, share disposal trusts, and marketable securities administration trusts.

Integrated Corporate Banking Business Group

The Integrated Corporate Banking Business Group covers all domestic and overseas corporate businesses, including commercial banking, investment banking, trust banking and securities businesses, as well as UnionBanCal Corporation (UNBC). UNBC is a wholly owned subsidiary of BTMU and a US bank holding company with Union Bank being its primary subsidiary. T! he Compan! y provides various financial solutions, such as loans and fund management, remittance and foreign exchange services. It also helps its customers develop business strategies, such as inheritance-related business transfers and stock listings.

It offers advanced financial solutions to companies through corporate and investment banking services. Product specialists globally provide derivatives, securitization, syndicated loans, structured finance and other services. It also provides investment banking services, such as merger and acquisition (M&A) advisory, bond and equity underwriting. It provides online banking services that allow customers to make domestic and overseas remittances electronically. It also provides a global cash pooling/netting service, and the Treasury Station, a fund management system for a multi-company group. The Company�� global Corporate and Investment Banking business (Global CIB), primarily serves companies, financial institutions, and sovereign and multinational organizations with a set of solutions for their financing needs.

Integrated Trust Assets Business Group

The Integrated Trust Assets Business Group covers asset management and administration services for products, such as pension trusts and security trusts by integrating the trust banking expertise of MUTB and the international strengths of BTMU. The business group provides a range of services to corporate and pension funds, including stable and secure pension fund management and administration, advice on pension schemes, and payment of benefits to scheme members. Its Integrated Trust Assets Business Group combines MUTB�� trust assets business, comprising trust assets management services, asset administration and custodial services, and the businesses of Mitsubishi UFJ Global Custody S.A., Mitsubishi UFJ Asset Management Co., Ltd. and KOKUSAI Asset Management Co., Ltd.

Advisors' Opinion:

• [By Louis Navellier]

  Mitsubishi UFJ Financial (NYSE:MTU) is a Japanese holding company mainly engaged in the banking business. Mitsubishi Financial has posted a gain of 11% since this time last year. MTU stock gets a “B” grade for operating margin growth, a “B” grade for the magnitude in which earnings projections have increased over the past months, and an “A” grade for cash flow.

10 Best Low Price Stocks To Own Right Now: Darford Intl Inc(WUF.V)

Darford International Inc. engages in the manufacture and distribution of dog treats and food primarily in Canada and the United States. The company also undertakes private label manufacturing contracts of pet treats. It sells its products under Darford brand name through wholesale distribution and retail partners. The company is headquartered in Vernon, British Columbia.

10 Best Low Price Stocks To Own Right Now: Aldridge Minerals Inc. (AGM.V)

Aldridge Minerals Inc., a junior exploration company, engages in the identification, exploration, and development of mineral properties in Turkey. Its principal property consists of the Yenipazar gold-silver-copper-zinc-lead deposit located in Turkey. The company was incorporated in 1994 and is based in Toronto, Canada.

10 Best Low Price Stocks To Own Right Now: OUM(OUM.AX)

Outback Metals Limited engages in the exploration of gold and other mineral deposits in Northern Territory, Australia. It holds interest in the Wingates gold project and the Mount Wells project located to the south of Darwin. The company is based in Hove, Australia.

10 Best Low Price Stocks To Own Right Now: InterMune Inc.(ITMN)

InterMune, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of therapies in pulmonology and fibrotic diseases. In pulmonology, the company focuses on therapies for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease. It markets pirfenidone, an orally active drug that inhibits the synthesis of TGF-beta under the Esbriet name in the European Union, as well as in a Phase III clinical trial in the United States. Pirfenidone is also approved for the treatment of IPF in Japan, where it is marketed by Shionogi & Co. Ltd. under the Pirespa trade name. The company?s research programs focus on the discovery of small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. InterMune, Inc. was founded in 1998 and is headquartered in Brisbane, California.

10 Best Low Price Stocks To Own Right Now: Seneca Foods Corp. (SENEA)

Seneca Foods Corporation produces and distributes processed fruits and vegetables. It offers canned, frozen, and bottled produce and snack chips, including canned fruits and vegetables, frozen vegetables, and other food products under private label, as well as national and regional brands that the it owns or licenses, including Seneca, Libby�s, Aunt Nellie�s Farm Kitchen, Stokely�s, Read, Taste of the West, Cimarron, Tendersweet, Blue Boy, Festa, and Seneca Farms. The company also packs Green Giant, Le Sueur, and other brands of canned vegetables, as well as select Green Giant frozen vegetables for General Mills Operations, LLC under a long-term alliance agreement. Seneca Foods sells its products to grocery outlets, including supermarkets, mass merchandisers, limited assortment stores, club stores, and dollar stores; and food service distributors, industrial markets, other food processors, and export customers in 80 countries, as well as to federal, state, and local gov ernments for school and other feeding programs. The company was founded in 1949 and is headquartered in Marion, New York.

Advisors' Opinion:

• [By Portfolio Grader]

  Seneca Foods (NASDAQ:SENEA) shows solid improvement this week. The company’s rating rises from a C to a B. Seneca Foods produces and distributes processed fruits and vegetables. The stock currently has a trailing PE Ratio of 9.30. 

10 Best Low Price Stocks To Own Right Now: Charming Shoppes Inc.(CHRS)

Charming Shoppes, Inc. operates as a specialty apparel retailer primarily for women in the United States. The company operates retail stores and related e-commerce Web sites under the LANE BRYANT, CACIQUE, LANE BRYANT OUTLET, FASHION BUG, FASHION BUG PLUS, and CATHERINES PLUS SIZES brand names. Its retail stores offer plus-size, junior, and misses sportswear, dresses, coats, and intimate apparel, as well as accessories and casual footwear. The company also sells food and specialty gifts through its Figi's Gifts in Good Taste catalog and related e-commerce Website, as well as through third-party retailers' stores. In addition, it operates FIGI'S Gallery that offers home decor, bedding, housewares, jewelry, garden accents, apparel, collectibles, gifts, and other items through its catalog and e-commerce Website. As of March 27, 2012, the company operated 1,857 retail stores in 48 states. Charming Shoppes, Inc. was founded in 1940 and is headquartered in Bensalem, Pennsylvania .

Why GM Still Owes Taxpayers Billions

As part of its high-speed trip through bankruptcy in 2009, General Motors (NYSE: GM  ) got a series of loans from the U.S. government -- $49.5 billion worth. GM has since paid the loans back with a mix of cash and stock, as agreed.

But here's the problem: The U.S. Treasury still doesn't have its money back, and as Fool contributor John Rosevear explains in this video, the feds probably don't have enough GM stock left to make things whole. So is that a problem for GM? Check out this video for all of the details, and then scroll down to leave a comment and let us know your thoughts.

China is already the world's largest auto market -- and it's set to grow even bigger in coming years. A recent Motley Fool report, "2 Automakers to Buy for a Surging Chinese Market," names two global giants poised to reap big gains that could drive big rewards for investors. You can read this report right now for free -- just click here for instant access.

Top 10 Energy Companies To Watch For 2014

Given the overall performance of the midstream industry during the past year and a half, a company that repeatedly offers up a poor performance come earnings time is going to stand out. Enbridge Energy Partners (NYSE: EEP  ) is one such company. In this video, Fool.com contributor Aimee Duffy takes a quick look at what is hurting EEP, how it compares to its midstream peers, and whether or not this master limited partnership has a bright future ahead of it.

The growing production of natural gas from hydraulic fracturing and horizontal drilling is flooding the North American market and resulting in record-low prices for natural gas. Enterprise Products Partners, with its superior integrated asset base, can profit from the massive bottlenecks in takeaway capacity by taking on large-scale projects. To help investors decide whether Enterprise Products Partners is a buy or a sell today, click here now to check out The Motley Fool's brand-new premium research report on the company.

Top 10 Energy Companies To Watch For 2014: Southern Union Company(SUG)

Southern Union Company, together with its subsidiaries, engages in the gathering, processing, transportation, storage, and distribution of natural gas in the United States. It operates in three segments: Transportation and Storage, Gathering and Processing, and Distribution. The Transportation and Storage segment engages in the interstate transportation and storage of natural gas in the Midwest and from the Gulf Coast to Florida. It also provides liquefied natural gas (LNG) terminalling and regasification services. The Gathering and Processing segment involves in gathering, treating, processing, and redelivering natural gas and natural gas liquids (NGLs) in Texas and New Mexico. It operates a network of approximately 5,500 miles of natural gas and NGL pipelines, 4 cryogenic processing plants with a combined capacity of 415 MMcf/d, and 5 natural gas treating plants with a combined capacity of 585 MMcf/d. The Distribution segment engages in the local distribution of natural gas in Missouri and Massachusetts. This segment serves residential, commercial, and industrial customers through local distribution systems. The company was founded in 1932 and is based in Houston, Texas.

Advisors' Opinion:

• [By Louis Navellier]

  Southern Union Co. (NYSE:SUG) also is involved with the gathering, processing, transportation, storage and distribution of natural gas in the U.S. Southern Union stock has jumped 74% year to date.

Top 10 Energy Companies To Watch For 2014: PetroChina Company Limited(PTR)

PetroChina Company Limited produces and distributes oil and gas in the People?s Republic of China. It operates in four segments: Exploration and Production, Refining and Chemicals, Marketing, and Natural Gas and Pipeline. The Exploration and Production segment explores, develops, produces, and markets crude oil and natural gas, oilsands, and coalbed methane. As of December 31, 2010, it had 11,278 million barrels of proved reserves of crude oil; and 65,503 billion cubic feet of proved reserves of natural gas. The Refining and Chemicals segment engages in the refining of crude oil and petroleum products; and production and marketing of petrochemical products, derivative petrochemical products, and other chemical products. This segment?s product line comprises processed crude oil, gasoline, kerosene, diesel, ethylene, synthetic resins, synthetic fiber materials, polymers, synthetic rubber, and urea. The Marketing segment involves in the marketing of refined products and tradi ng businesses. It operated 17,996 service stations. The Natural Gas and Pipeline segment engages in the transmission of natural gas, crude oil, and refined products; and the sale of natural gas. It had a total length of 56,840 kilometers (km) of oil and gas pipelines, including 32,801 km of natural gas pipelines, 14,782 km of crude oil pipelines, and 9,257 km of refined product pipelines. The company was founded in 1988 and is headquartered in Beijing, the People?s Republic of China. PetroChina Company Limited is a subsidiary of China National Petroleum Corporation.

Advisors' Opinion:

• [By Smith]  

  With a market capitalization of $260 billion, PetroChina is at the top of our list. The company has a regular dividend policy and last year's dividend yield was 3%. Its global competitors, such Royal Dutch Shell (RDS.A), British Petrolum (BP), Chevron Corporation (CVX) and Exxon Mobil (XOM), are competing fiercely. Meanwhile, PetroChina has an almost monopolistic position in China. In the last 10 years, the stock price increased 10-fold, from $15 in 2001 to $150 in 2010. That's a 1000% return within the last 10 years excluding dividends.

5 Best Stocks For 2014: Hoku Corporation(HOKU)

Hoku Corporation operates as a solar energy products and services company primarily in the United States. It focuses on manufacturing polysilicon, a primary material used in the manufacture of photovoltaic (PV) modules; and designing, engineering, and installing turnkey PV systems and related services in Hawaii using solar modules purchased from third-party suppliers. The company was formerly known as Hoku Scientific, Inc. and changed its name to Hoku Corporation in March 2010. Hoku Corporation was incorporated in 2001 and is headquartered in Honolulu, Hawaii.

Advisors' Opinion:

• [By Chuck]

  Hoku Corp.(NASDAQ: HOKU) closing price in the stock market Tuesday, Jan. 3, was $0.5501. HOKU is trading -32.79% below its 50 day moving average and -61.84% below its 200 day moving average. HOKU is -80.90% below its 52-week high of $3.24 and 10.02% above its 52-week low of $0.50. HOKU‘s PE ratio is N/A and its market cap is $30.21M.

  Hoku Corp. operates as a solar energy products and services company primarily in the United States. HOKU focuses on manufacturing polysilicon, a primary material used in the manufacture of photovoltaic (PV) modules; and designing, engineering, and installing turnkey PV systems and related services in Hawaii using solar modules purchased from third-party suppliers.

Top 10 Energy Companies To Watch For 2014: Precision Drilling Corp (PDS)

Precision Drilling Corporation (Precision) is a provider of contract drilling and completion and production services primarily to oil and natural gas exploration and production companies in Canada and the United States. The Company operates in two segments: Contract Drilling Services, and Completion and Production Services. In Canada, the Contract Drilling Services segment includes land drilling services, directional drilling services, procurement and distribution of oilfield supplies and the manufacture and refurbishment of drilling and service rig equipment, and the Completion and Production Services segment includes service rigs for well completion and workover services, snubbing services, camp and catering services, wastewater treatment services and the rental of oilfield surface equipment, tubulars, well control equipment and wellsite accommodations. Advisors' Opinion:

• [By Louis Navellier]

  Dahlman Rose, an investment bank specializing in natural resources, upgraded the oil services industry in November 2012; one of the prime recipients of this upgrade was Precision Drilling, Canada's largest oilfield services company. Dahlman Rose expects North American exploration and production to increase by 11% in 2013 to $334 billion, led by a big increase from natural gas. The investment banker believes land drillers like Precision are selling at a historically low multiple of 1.1 times tangible book value compared to the historical norm of two times tangible book value. Heading into 2013, Precision's stock's dropped a significant amount and sits at one of its lowest levels in the past two years. Despite reduced demand for its services in 2012, CEO Kevin Neveu pointed out in October that, "PDS is seeing increased long-term contracts for upgraded and new rigs." Rising natural gas prices should increase the industry's rig utilization rate to around 85%, naturally increasing Precision's revenues and profits. This could be an easy double in 2013. 

Top 10 Energy Companies To Watch For 2014: Yingli Green Energy Holding Company Limited(YGE)

Yingli Green Energy Holding Company Limited, together with its subsidiaries, engages in the design, development, manufacture, marketing, sale, and installation of photovoltaic (PV) products in the People?s Republic of China and internationally. The company offers PV cells, PV modules, and integrated PV systems, as well as polysilicon ingots, blocks, and wafers. It sells its PV modules to distributors, wholesalers, power plant developers and operators, and PV system integrators in Germany, the United States, Italy, China, Spain, the Netherlands, Greece, the Czech Republic, the United Kingdom, South Korea, and Japan under the Yingli and Yingli Solar brand names. The company also offers its integrated PV systems directly to end-users or to contractors for use in the electricity projects, as well as to mobile communications companies in the People's Republic of China. Yingli Green Energy Holding Company Limited was founded in 1998 and is headquartered in Baoding, the People? s Republic of China.

Advisors' Opinion:

• [By Hawkinvest]

  Yingli Green Energy (YGE) is one of the largest solar companies in China, and it recently announced that it expects to recognize an impairment charge of about $361 million and an impairment of goodwill for about $43 million in the fourth quarter of 2011. Yingli plans to announce fourth quarter and full year results for 2011 on February 29, 2012. It makes sense to wait for an update on the financial results from the company before making a significant investment. If the stock remains stable after earnings, it could be a positive sign that it has reached a bottom.

  This company has a debt load which concerns some investors, but it is posting smaller losses when compared to other solar companies. When the solar stocks were at a cyclical peak around December 2007, Yingli shares traded for about $38 per share. Now the stock can be bought for less than one-tenth of that price. The impairment charges this company plans to take is a sign that it is making tough choices and possibly positioning it for a future rebound.

• [By Harding]

  Yingli Green Energy Holding Co., Ltd.(NYSE: YGE) closing price in the stock market Tuesday, Jan. 3, was $4.07. YGE is trading 4.05% above its 50 day moving average and -22.09% below its 200 day moving average. YGE is -70.05% below its 52-week high of $13.59 and 48.00% above its 52-week low of $2.75. YGE‘s PE ratio is 3.79 and its market cap is $643.85M.

  Yingli Green Energy Holding Co., Ltd. engages in the design, development, manufacture, marketing, sale, and installation of photovoltaic (PV) products in the People’s Republic of China and internationally.

• [By Jim Jubak]

   Yipes! A Chinese solar stock? Everyone knows that the market for solar cells has collapsed and that China's solar sector is awash in unused capacity and desperate companies barely clinging to life. Exactly --everybody knows. So what does it take to move a stock like Yingli Green Energy (YGE)?

  It doesn't take much. Some positive speculation that Yingli and competitor Trina Solar (TSL) are well-financed enough  to be among the survivors in the sector would do it. (Yingli can sustain the 2013 cash burn rate for four years, Credit Suisse calculates.) Yingli would also be helped by news of China's State Council encouraging mergers and acquisitions (and maybe even a bankruptcy) in an effort to reduce capacity in the sector -- and banning local government financing of the sort that has kept Suntech Power (STP) and LDK Solar (LDK) in business. There's also a new, high-profile target for increased buying of solar equipment by China's power companies. That last factor has been especially important to Yingli Green Energy, since the company is set to receive orders under the government-funded program.

  Shares of Yingli Green Energy have just about doubled from a Nov. 21 low of $1.28 to a Dec. 19 price of $2.44. But there's room to run; the 52-week high is $6.27.

Top 10 Energy Companies To Watch For 2014: Alterra Power Corp (MGMXF.PK)

Alterra Power Corp., formerly Magma Energy Corp., is a global renewable power company. It operates six power plants totaling 570 megawatt of capacity, including two geothermal facilities in Iceland, a geothermal plant in Nevada, British Columbia�� run of river hydro facilities and the province�� wind farm. As of June 30, 2011, its share of this production capacity was 315 megawatt. The Company also has a portfolio of exploration and development projects. The Company owns two geothermal power generation plants (the Svartsengi and Reykjanes Plants) and two geothermal exploration projects in Iceland (Eldvorp and Krysuvik) through its interest in HS Orka. In addition, it owns one geothermal power generation plant in Nevada (the Soda Lake Operation). In May 2011, it acquired Plutonic Power Corp. During the fiscal year ended June 30, 2011 (fiscal 2011), it sold a 25% interest in HS Orka to Jardvarmi slhf (Jardvarmi), which is a company-owned by a group of Icelandic pension f unds.

Top 10 Energy Companies To Watch For 2014: ENSCO plc(ESV)

Ensco plc, together with its subsidiaries, provides offshore contract drilling services to the oil and gas industry. The company engages in the drilling of offshore oil and natural gas wells by providing its drilling rigs and crews under contracts with international, government-owned, and independent oil and gas companies. As of February 15, 2010, it owned and operated 42 jackup rigs, 4 ultra-deepwater semisubmersible rigs, and 1 barge rig. The company also has 4 ultra-deepwater semisubmersible rigs under construction. It operates in Asia, the Middle East, Australia, New Zealand, Europe, Africa, and North and South America. The company was formerly known as Ensco International plc and changed its name to Ensco plc in March 2010. Ensco plc was founded in 1975 and is based in London, the United Kingdom.

Advisors' Opinion:

• [By Skousen]

  Ensco is a global offshore contract drilling company. Cramer holds 2,100 shares of ESV stocks. ESV has a dividend yield of 2.97% and returned -5.86% since the beginning of this year. It has a market cap of $10.94B and a P/E ratio of 16.54. Robert Rodriguez and Steven Romick invested $429 million in ESV

Top 10 Energy Companies To Watch For 2014: Apache Corporation(APA)

Apache Corporation, together with its subsidiaries, engages in the exploration, development, and production of natural gas, crude oil, and natural gas liquids. The company has exploration and production interests in the Gulf of Mexico, the Gulf Coast, east Texas, the Permian basin, the Anadarko basin, and the Western Sedimentary basin of Canada; and onshore Egypt, offshore Western Australia, offshore the United Kingdom in the North Sea, and onshore Argentina, as well as on the Chilean side of the island of Tierra del Fuego. Apache Corporation sells its natural gas to local distribution companies, utilities, end-users, integrated oil and gas companies, and marketers; and crude oil to integrated oil companies, marketing and transportation companies, and refiners. As of December 31, 2009, it had total estimated proved reserves of 1,067 million barrels of crude oil, condensate, and natural gas liquids, as well as 7.8 trillion cubic feet of natural gas. The company was founded in 1954 and is based in Houston, Texas.

Advisors' Opinion:

• [By Sherry Jim]

  Apache Corp (NYSE: APA): APA is the largest US energy stock in Cramer’s trust. As of Feb. 15, the fund owns 1050 shares of APA, which is worth about $113,000. APA is also quite popular among hedge funds. At the end of the third quarter, there were 30 hedge funds with APA positions. Jean-Marie Eveillard’s First Eagle Investment Management had $147 million invested, and Ric Dillon and Boykin Curry were also bullish about the stock, each with more than $100 million invested in APA at the end of September.

  We agree with these hedge fund managers. In late January, APA announced that it agreed to acquire Cordillera Energy Partners III LLC for $2.85 billion. Cordillera has nearly 254,000 net acres in the Anadarko Basin of Texas. It also has reserves of 71.5 million barrels of oil equivalent and its current net production is about 18,000 barrels per day. The acquisition will also provide APA with about 14,000 potential drilling locations. APA is already trading at attractive multiples. Its forward P/E ratio is 8.78 and its EPS is expected to grow at 11.22% on the average per year over the next five years. So its P/E ratio for 2014 is only 7.02.

Top 10 Energy Companies To Watch For 2014: ATP Oil And Gas Corp (AOB)

ATP Oil & Gas Corporation, incorporated in 1991, is engaged in the acquisition, development and production of oil and natural gas properties. As of December 31, 2011, the Company had estimated net proved reserves of 118.9 Million barrels of crude oil equivalent (MMBoe), of which approximately 75.9 MMboe (64%) were in the Gulf of Mexico and 42.9 MMBoe (36%) were in the North Sea. The reserves consisted of 78.6 Million barrels (MMBbls) of oil (66%) and 241.5 billion cubic feet (Bcf) of natural gas (34%). Its proved reserves in the deepwater area of the Gulf of Mexico account for 62% of the Company�� total proved reserves and its proved reserves on the Gulf of Mexico Outer Continental Shelf account for 2% of its total proved reserves. During the year ended December 31, 2011, the Company acquired three licenses in the Mediterranean Sea covering potential natural gas resources in the deepwater off the coast of Israel (East Mediterranean). On August 17, 2012, ATP Oil And Gas Corp filed for Chapter 11 bankruptcy protection.

The Company�� natural gas reserves are split between the Gulf of Mexico (57%) and the North Sea (43%). Of its total proved reserves, 8.3 MMBoe (7%) were producing, 19.0 MMBoe (16%) were developed and not producing and 91.6 MMBoe (77%) were undeveloped. The Company�� average working interest in its properties at December 31, 2011, was approximately 81%. The Company operates 92% of its platforms. At December 31, 2011, in the Gulf of Mexico, it owned leasehold and other interests in 38 offshore blocks and 49 wells, including 23 subsea wells. The Company operates 43 (88%) of these wells, including 100% of the subsea wells. In the North Sea, it also had interests in 13 blocks and two Company-operated subsea wells. As of March 15, 2011, the Company owned an interest in 13 platforms, including two floating production facilities in the Gulf of Mexico, the ATP Titan at its Telemark Hub and the ATP Innovator at its Gomez Hub. It operates the ATP Innovator and the ATP Titan.

Top 10 Energy Companies To Watch For 2014: Euro FX(P)

Ecopetrol S.A. operates as an integrated oil company in Colombia, Peru, Brazil, and the U.S. Gulf Coast. The company engages in the exploration, development, and production of crude oil and natural gas. As of December 31, 2010, its proved reserves of crude oil and natural gas consisted of 1,714.0 million barrels of oil equivalent. The company also transports crude oil, motor fuels, fuel oil, and other refined products, as well as mixture of diesel and palm oil. It owns transportation network consisting of 3,003 kilometers of crude oil pipeline directly, as well as an additional 2,178 kilometers of crude oil pipeline with its business partners; and 3,017 kilometers of multi-purpose pipelines for transportation of refined products from refinery to wholesale distribution points. As of the above date, Ecopetrol S.A. owned 58 stations with a nominal storage capacity of 19 million barrels of crude oil and 6 million barrels of refined products. In addition, the company owns and o perates refineries that produce a range of refined products, including gasoline, diesel, kerosene, jet fuel, aviation fuel, liquefied petroleum gas, sulfur, heavy fuel oils, motor fuels, and petrochemicals, including paraffin waxes, lube base oils, low-density polyethylene, aromatics, asphalts, alkylates, cyclohexane and aliphatic solvents, and refinery grade propylene, as well as provides industrial services to third parties. Further, it markets various refined and feed stock products, including regular and high octane gasoline, diesel fuel, jet fuel, natural gas, and petrochemical products. The company was formerly known as Empresa Colombiana de Petroleos and changed its name to Ecopetrol S.A. in June 2003. Ecopetrol S.A. was founded in 1948 and is based in Bogota, Colombia.

Advisors' Opinion:

• [By Ryan Peckyno]

  The final stock was Pandora Media, which was designated as “the top small-cap pick.”  Of all of the stocks recommended, based on the target price of $14 this stock has the most upside potential: 27%.  The rationale appeared to be that Pandora is well-positioned to gain market share and once it does that Pandora can then improve its margins. 

10 Best Biotech Stocks To Buy Right Now

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biotechnology company Idenix Pharmaceuticals (NASDAQ: IDIX  ) has received a distressing two-star ranking.

With that in mind, let's take a closer look at Idenix and see what CAPS investors are saying about the stock right now.

Idenix facts

Headquarters	Cambridge, Mass. (1998)
Market Cap	$649.7 million
Industry 10 Best Biotech Stocks To Buy Right Now: Dendreon Corporation(DNDN) Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients. The company offers active cellular immunotherapy and small molecule product candidates to treat various cancers. Its product candidates comprise Provenge (sipuleucel-T), an active cellular immunotherapy for the treatment of metastatic, castrate-resistant prostate cancer; DN24-02, an investigational active immunotherapy for the treatment of patients with bladder, breast, ovarian, and other solid tumors expressing HER2/neu; and TRPM8, a small molecule agonist to transient receptor potential ion channel, for multiple cancers. The company also has a range of products in preclinical studies, which include Carcinoembryonic antigen for the treatment of lung, colon, and breast cancer; and Carbonic AnhydraseIX for the treatment of kidney cancer. Dendreon Corporation was founded in 1992 and is headquartered in S eattle, Washington. 10 Best Biotech Stocks To Buy Right Now: Galena Biopharma Inc (GALE.PH) Galena Biopharma, Inc. (Galena), formerly RXi Pharmaceuticals Corporation, incorporated on April 3, 2006, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using targeted biotherapeutics. The Company is pursuing the development of cancer therapeutics using peptide-based immunotherapy products, including its main product candidate, NeuVaxTM (E75), for the treatment of breast cancer and other tumors. NeuVax is a peptide-based immunotherapy intended to reduce the recurrence of breast cancer in low-to-intermediate HER2-positive breast cancer patients not eligible for trastuzumab (Herceptin; Genentech/Roche). On January 19, 2012, the Company initiated enrollment in its Phase 3 PRESENT clinical trial for NeuVax (E75 peptide plus GM-CSF) vaccine in low-to-intermediate HER2 1+ and 2+ breast cancer patients in the adjuvant setting to prevent recurrence (Clinicaltrials.gov identifier NCT01479244). The Preven tion of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment study is a randomized, multicenter, multinational clinical trial that will enroll approximately 700 breast cancer patients. The Company�� Phase 2 trial of NeuVax achieved its primary endpoint of disease-free survival (DFS). On April 13, 2011, the Company completed its acquisition of Apthera, Inc.,(Apthera). The Company focuses to start a Phase 2 trial comparing NeuVax in combination with trastuzumab (Herceptin) versus trastuzumab, alone, in a 300-patient, randomized study in the adjuvant breast cancer setting. The Company's second product candidate, Folate Binding Protein-E39 (FBP), is a vaccine, consisting of the peptides E39 and J65, aimed at preventing the recurrence of ovarian, endometrial, and breast cancers. On February 14, 2012, the Company announced the initiation of a Phase 1/2 clinical trial in two gynecological cancers: ovari an and endometrial adenocarcinomas. Folate binding protein! h! as very limited tissue distribution and expression in non-malignant tissue and is over-expressed in more than 90% of ovarian and endometrial cancers, as well as in 20% to 50% of breast, lung, colorectal and renal cell carcinomas. In April 2011, the Company acquired Apthera Inc and its NeuVax product candidate. The Company focuses on developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide, the advanced of which is NeuVax, which is targeted at preventing the recurrence of breast cancer. NeuVax has had positive Phase 1/2 clinical trial results for the prevention of breast cancer recurrence in patients who have had breast cancer and received the standard of care treatment (surgery, chemotherapy, radiotherapy and hormonal therapy as indicated). The Company had also initiated its Phase 3 PRESENT clinical trial of NeuVax for the prevention of breast cancer recurrence in early-stage low-to-intermediate HER2 breast cancer patients. NeuVax directs killer T-cells to target and destroy cancer cells that express HER2/neu, a protein associated with epithelial tumors in breast, ovarian, pancreatic, colon, bladder and prostate cancers. NeuVax is comprised of a HER2/neu-derived peptide called E75. E75 is a nine-amino acid sequence that is immunogenic (produces an immune response) and GM-CSF is a commercially available protein that acts to stimulate and activate components of the immune system such as macrophages and dendritic cells. The Company also develops novel applications for NeuVax based on preclinical studies and phases 2 clinical trials which suggest that combining NeuVax and trastuzumab (Herceptin; Genentech/Roche) can increase antigen presentation by tumor cells by promoting receptor internalization and subsequent proteosomal degradation of the HER2 protein. The Company also is pursuing additional therapeutic indications for NeuVax that are in Phase 1/2 clinical trials. RXI-109, is a dermal anti-scarring therapy that ! targ! ets! conne! ctive tissue growth factor (CTGF) and that may inhibit connective tissue formation in human fibrotic disease. The Company competes with Roche Laboratories, Inc., Pfizer Inc., Bayer HealthCare AG, Sanofi-Aventis, US, LLC, Amgen, Inc., GlaxoSmithKline plc, Renovo Group plc, CoDa Therapeutics, Inc., Sirnaomics, Inc., FirstString Research, Inc., Merz Pharmaceuticals, LLC, Capstone Therapeutics, Halscion, Inc., Garnet Bio Therapeutics, Inc., AkPharma Inc., Promedior, Inc., Kissei Pharmaceutical Co., Ltd., Eyegene, Derma Sciences, Inc., Healthpoint Biotherapeutics, Pharmaxon, Excaliard Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., Marina Biotech, Inc., Tacere Therapeutics, Inc., Benitec Limited, OPKO Health, Inc., Silence Therapeutics plc, Quark Pharmaceuticals, Inc., Rosetta Genomics Ltd., Lorus Therapeutics, Inc., Tekmira Pharmaceuticals Corporation, Arrowhead Research Corporation, Regulus Therapeutics Inc. and Santaris. Top Stocks To Watch For 2014: Telik Inc (TELK.PH) Telik, Inc. (Telik), incorporated in 1988, is a clinical-stage drug development company focused on discovering and developing small molecule drugs to treat cancer. The Company discovers its product candidates using the Company�� drug discovery technology, Target-Related Affinity Profiling (TRAP). TELINTRA, its principal drug product candidate in clinical development, is a small molecule glutathione analog inhibitor of the enzyme glutathione S-transferase P1-1 (GST P1-1). TELCYTA, its other product candidate, is a small molecule cancer drug product candidate designed to be activated in cancer cells. Clinical Product Development TELINTRA is the Company�� lead small molecule product candidate in clinical development for the treatment of blood disorders, including cancer. It has a mechanism of action and acts by inhibiting GST P1-1, an enzyme that is involved in the control of cellular growth and differentiation. Inhibition of GST P1-1 results in the activation of the signaling molecule Jun kinase, a regulator of the function of blood precursor cells. Preclinical tests show that TELINTRA is capable of causing the death or apoptosis of leukemic or malignant blood cells, while stimulating the growth and development of normal blood precursor cells. TELINTRA has been studied in Myelodysplastic Syndrome (MDS) using two formulations. A liposomal formulation was developed for intravenous administration of TELINTRA and was used in Phase I and Phase II studies in MDS patients. The results from the Phase II intravenous liposomal TELINTRA clinical trials demonstrated that TELINTRA treatment was associated with improvement in all three types of blood cell levels in patients with all types of MDS, including those in intermediate and high-risk groups. An oral dosage formulation (tablet) was subsequently developed and results from a Phase I study with TELINTRA tablets showed clinical activity and the formulation to be well tole rated. In June 2011, the Company initiated a Phase II clini! c! al trial to evaluate TELINTRA tablets. In October 2011, the Company initiated an additional Phase IIb clinical trial to evaluate TELINTRA tablets. ' The activity and safety profile of tablet formulation allowed the Company to complete a Phase II trial of TELINTRA tablets in MDS. The primary objective of the Phase II TELINTRA tablet study was to determine the efficacy of TELINTRA. A multivariate logistic regression analysis was conducted to identify MDS disease prognostic factors associated with erythroid improvement response rates, including prior MDS treatment, age, gender, the international prognostic scoring system (IPSS), risk, Eastern Cooperative Group performance status, years from MDS diagnosis, MDS World Health Organization subtypes, anemia only versus anemia plus other cytopenias, dose schedule and starting dose. Results from this study show that TELINTRA is the first GSTP1-1 enzyme inhibitor shown to cause clinically reductions in red blood cell transf usions, including transfusion independence in low to intermediate-1 risk MDS patients, as well as improvement in platelet count and white blood cell levels in certain patients. TELINTRA, administered orally twice daily, appeared to be convenient and flexible for chronic treatment administration. TELCYTA is a small molecule drug product candidate that the Company is developed for the treatment of cancer. TELCYTA binds to GST. TELCYTA has been evaluated in multiple Phase II and Phase III clinical trials, including trials using TELCYTA as monotherapy and in combination regimens in ovarian, non-small cell lung, breast and colorectal cancer. Results from these clinical trials indicate that TELCYTA monotherapy was generally well-tolerated, with mostly mild to moderate side effects, particularly when compared to the side effects and toxicities of standard chemotherapeutic drugs. When TELCYTA was evaluated in combination with standard chemotherapeutic drugs, the tolera bility of the combinations was similar to that expected! of e! ac! h drug ! alone. Clinical activity including objective tumor responses and/or disease stabilization was reported in the TELCYTA Phase II trials; however, TELCYTA did not meet its primary endpoints in the Phase III studies. Positive results from a Phase I-IIa multicenter, dose-ranging study of TELCYTA in combination with carboplatin and paclitaxel as first-line therapy for patients with non-small cell lung cancer, or NSCLC, were published in a peer reviewed publication. Clinical data demonstrated positive results of TELCYTA in combination with carboplatin and paclitaxel in the treatment of first-line lung cancer followed by TELCYTA maintenance therapy. As of December 31, 2011, the Company had an on-going investigator-led study at a single site of TELCYTA in patients with refractory or relapsed mantle cell lymphoma, diffuse B cell lymphoma, and multiple myeloma. Preclinical Drug Product Development The Company has a small molecule compound, TLK60 404, in preclinical development that inhibits both Aurora kinase and VEGFR kinase. Aurora kinase is a signaling enzyme whose function is required for cancer cell division, while VEGF plays a key role in tumor blood vessel formation, ensuring an adequate supply of nutrients to support tumor growth. These lead compounds prevented tumor growth in preclinical models of human colon cancer and human leukemia by inhibiting both Aurora kinase and VEGFR kinase. A development drug product candidate, TLK60404, has been selected. The Company, using its TRAP technology has discovered TLK60357, a novel, potent small molecule inhibitor of cell division. TLK60357 inhibits the formation of microtubules that are necessary for cancer cell growth leading to persistent G2/M cancer cell cycle block and subsequent cell death. This compound demonstrates potent broad-spectrum anticancer activity against a number of human cancer cells. This compound also displays oral efficacy in multipl e, standard preclinical models of cancer. TLK6059! 6, a pote! nt! VGFR kin! ase inhibitor, blocks the formation of new blood vessels in tumors. Oral administration of TLK60596 to animal models of human colon cancer reduced tumor growth. 10 Best Biotech Stocks To Buy Right Now: ViroPharma Incorporated(VPHM) ViroPharma Incorporated, a biotechnology company, develops and commercializes therapeutic products that address serious diseases in the United States and internationally. It focuses on developing products used by physician specialists or in hospital settings. The company markets and sells Cinryze, a C1 esterase inhibitor therapy for the routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema, a life-threatening genetic disorder; and Vancocin HCl capsule, an oral capsule formulation for the treatment of C. difficile-associated diarrhea (CDAD) and to treat enterocolitis caused by staphylococcus aureus, including methicillin-resistant strains. It also offers Plenadren, an orphan drug for treatment of adrenal insufficiency in adults; Buccolam, a oromucosal solution for treatment of prolonged, acute, and convulsive seizures in infants, toddlers, children, and adolescents; and maribavir, an antiviral compound for the treatment o f CMV disease through a license agreement with GlaxoSmithKline. The company?s primary development programs include Cinryze, a C1 esterase inhibitor for management of hereditary angioedema; and VP 20621, a non-toxigenic strain of C. difficile. Its clinical stage drug candidate comprises VP-20629 for the treatment of Friedreich?s Ataxia. The company sells its products directly to wholesale drug distributors and specialty pharmacies/distributors. ViroPharma Incorporated was founded in 1994 and is headquartered in Exton, Pennsylvania. Advisors' Opinion: [By Harding] ViroPharma Inc. specializes in drug development and commercialization for medications to treat C. difficile, Staph. aureus and other infectious diseases found in hospital settings. Their pipeline includes a number of products in Phase II and III trials, two on the market, and they have strategic relations with giants like EliLilly and GlaxoSmithKline. VPHM stock, worth about $8 in January 2012, is priced at nearly $13 today, and is still steadily climbing. The company, founded in 1994, employs 170 people. 10 Best Biotech Stocks To Buy Right Now: Savient Pharmaceuticals Inc(SVNT) Savient Pharmaceuticals, Inc., a specialty biopharmaceutical company, focuses on developing KRYSTEXXA, a biologic PEGylated uricase in the United States. The KRYSTEXXA is being developed as a treatment for chronic gout in patients refractory to conventional therapy. The company also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. It sells its products directly to drug wholesalers. The company, formerly known as Bio-Technology General Corp. and changed its name to Savient Pharmaceuticals, Inc. in June 2003. Savient Pharmaceuticals, Inc. was founded in 1980 and is headquartered in East Brunswick, New Jersey. 10 Best Biotech Stocks To Buy Right Now: Cannabis Science Inc (CBIS) Cannabis Science, Inc., incorporated on May 4, 2007, is a development-stage company. The Company is engaged in the creation of cannabis-based medicines, both with and without psychoactive properties, to treats disease and the symptoms of disease, as well as for general health maintenance. On February 9, 2012, the Company acquired GGECO University, Inc. (GGECO). On March 21, 2012, the Company acquired Cannabis Consulting Inc. (CCI Group). The Company is engaged in medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. 10 Best Biotech Stocks To Buy Right Now: Cell Therapeutics Inc (CTIC) Cell Therapeutics, Inc. (CTI), incorporated in 1991, develops, acquires and commercializes treatments for cancer. The Company�� research, development, acquisition and in-licensing activities concentrate on identifying and developing new ways to treat cancer. As of December 31, 2011, CTI focused its efforts on Pixuvri (pixantrone dimaleate) (Pixuvri), OPAXIO (paclitaxel poliglumex) (OPAXIO), tosedostat, brostallicin and bisplatinates. As of December 31, 2011, it developed Pixuvri, an anthracycline derivative for the treatment of hematologic malignancies and solid tumors. Another late-stage drug candidate of the Company, OPAXIO, is being studied as a potential maintenance therapy for women with advanced stage ovarian cancer, who achieve a complete remission following first-line therapy with paclitaxel and carboplatin. As of December 31, 2011, it also developed tosedostat in collaboration with Chroma Therapeutics, Ltd. (Chroma). On May 31, 2012, CTI completed its acquisition gaining worldwide rights to S*BIO Pte Ltd.'s (S*BIO) pacritinib. Pixuvri As of December 31, 2011, the Company developed Pixuvri, an aza-anthracenedione derivative, for the treatment of non-Hodgkin�� lymphoma (NHL), and various other hematologic malignancies, and solid tumors. Pixuvri was studied in the Company�� EXTEND, or PIX301, clinical trial, which was a phase III single-agent trial of Pixuvri for patients with relapsed, refractory aggressive NHL who received two or more prior therapies and who were sensitive to treatment with anthracyclines. On September 28, 2011, CTI announced that a second independent radiology assessment of response and progression endpoint data from its PIX301 clinical trial of Pixuvri was achieved with statistical significance. The results of the EXTEND trial met its primary endpoint and showed that patients randomized to treatment with Pixuvri achieved a significantly higher rate of confirmed and unconfirmed complete response compared to patients treated with standard chem! otherapy had a significantly increased overall response rate and experienced a statistically significant improvement in median progression free survival. Pixuvri had predictable and manageable toxicities when administered at the proposed dose and schedule in the EXTEND clinical trial in heavily pre-treated patients. In March 2011, the Company initiated the PIX-R trial to study Pixuvri in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). Pixuvri has also been studied in patients with HER2-negative metastatic breast cancer who have tumor progression after at least two, but not more than three, prior chemotherapy regimens. In the second quarter of 2010, the NCCTG opened this phase II study for enrollment. The study is closed to accrual and results are expected to be reported by the NCCTG later in 2012. OPAXIO OPAXIO is the Company�� biologically-enhanced chemotherapeutic agent that links paclitaxel to a biodegradable polyglutamate polymer, resulting in a new chemical entity. As of December 31, 2011, the Company focused its development of OPAXIO on ovarian, brain, esophageal, head and neck cancer. OPAXIO was designed to improve the delivery of paclitaxel to tumor tissue while protecting normal tissue from toxic side effects. In November 2010, results were presented by the Brown University Oncology Group from a phase II trial of OPAXIO combined with temozolomide (TMZ), and radiotherapy in patients with newly-diagnosed, high-grade gliomas, a type of brain cancer. The trial demonstrated a high rate of complete and partial responses and a high rate of six month progression free survival (PFS). Based on these results, the Brown University Oncology Group has initiated a randomized, multicenter, phase II study of OPAXIO and standard radiotherapy versus TMZ and radiotherapy for newly diagnosed patients with glioblastoma with an active gene termed MGMT that reduces responsiveness to TMZ. A phase I/II study of OPAXIO combined with radi! otherapy ! and cisplatin was initiated by SUNY Upstate Medical University, in patients with locally advanced head and neck cancer. Tosedostat In March 2011, the Company entered into a co-development and license agreement with Chroma Therapeutics, Ltd. (Chroma), providing the Company with marketing and co-development rights to Chroma�� drug candidate, tosedostat, in North, Central and South America. Tosedostat is an oral, aminopeptidase inhibitor that has demonstrated anti-tumor responses in blood related cancers and solid tumors in phase I-II clinical trials. Interim results from the phase II OPAL study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia (AML) showed that once-daily, oral doses of tosedostat had predictable and manageable toxicities and results demonstrated response rates, including a high-response rate among patients who received prior hypomethylating agents, which are used to treat myelodysplastic syndrome (MDS), a precursor of AML. Brostallicin As of December 31, 2011, the Company developed brostallicin through its wholly owned subsidiary, Systems Medicine LLC, which holds rights to use, develop, import and export brostallicin. Brostallicin is a synthetic deoxyribonucleic acid (DNA) minor groove binding agent that has demonstrated anti-tumor activity and a favorable safety profile in clinical trials, in which more than 230 patients have been treated as of December 31, 2011. The Company uses a genomic-based platform to guide the development of brostallicin. A phase II study of brostallicin in relapsed, refractory soft tissue sarcoma met its predefined activity and safety hurdles and resulted in a first-line phase II clinical trial study that was conducted by the European Organization for Research and Treatment of Cancer (EORTC). The Company competes with Bristol-Myers Squibb Company, Sanofi-Aventis, Pfizer, Roche Group, Genentech, Inc., Astellas Pharma, Eli Lilly and Company, Celgene, Telik, I! nc., TEVA! Pharmaceuticals Industries Ltd. and PharmaMar. 10 Best Biotech Stocks To Buy Right Now: Quintiles Transnational Holdings Inc (Q) Quintiles Transnational Holdings Inc. is a provider of biopharmaceutical development services and commercial outsourcing services. The Company operates in two segments: Product Development and Integrated Healthcare Services. The Company�� Product Development segment operates as a contract research organization (CRO) focused primarily on Phase II-IV clinical trials and associated laboratory and analytical activities. The Company�� Integrated Healthcare Services segment is a global commercial pharmaceutical sales and service organizations and Integrated Healthcare Services provides a range of services, including commercial services, such as providing contract pharmaceutical sales forces in geographic markets, as well as healthcare business services for the healthcare sector, such as outcome-based and payer and provider services. In August 2012, it acquired Expression Analysis, Inc. Product Development Product Development provides services and that allow biopharmaceutical companies to outsource the clinical development process from first in man trials to post-launch monitoring. The Company�� service offering provides the support and functional necessary at each stage of development, as well as the systems and analytical capabilities. Product Development consists of clinical solutions and services and consulting. Clinical solutions and services provides services necessary to develop biopharmaceutical products, including project management and clinical monitoring functions for conducting multi-site trials (generally Phase II-IV) (core clinical) and clinical trial support services that improve clinical trial decision making and include global laboratories, data management, biostatistical, safety and pharmacovigilance, and early clinical development trials, and strategic planning and design services that improve decisions and performance. Consulting provides strategy and management consulting services based on life science and advanced analytics, as well as regulatory and comp! liance consulting services. The Company competes with Covance, Inc., Pharmaceutical Product Development, Inc., PAREXEL International Corporation, ICON plc, inVentiv Health, Inc. (inVentive), INC Research and PRA International. Integrated Healthcare Services Integrated Healthcare Services provides the healthcare industry with both geographic presence and commercial capabilities. The Company�� commercialization services are designed to accelerate the commercial of biopharmaceutical and other health-related products. Service offerings include commercial services (sales representatives, strategy, marketing communications and other areas related to commercialization), outcome research (drug therapy analysis, real-world research and evidence-based medicine, including research studies to prove a drug�� value) and payer and provider services comparative and cost-effectiveness research capabilities, clinical management analytics, decision support services, medication adherence and health outcome optimization services, and Web-based systems for measuring quality improvement. The Company competes with inVentiv, PDI, Inc., Publicis Selling Solutions, United Drug plc, EPS Corporation and CMIC HOLDINGS Co., Ltd. 10 Best Biotech Stocks To Buy Right Now: Alnylam Pharmaceuticals Inc.(ALNY) Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). Its core product programs under clinical or pre-clinical development include ALN-TTR, a Phase I clinical trial program for the treatment of transthyretin-mediated amyloidosis; ALN-APC, a Phase I clinical trial program for the treatment of hemophilia; ALN-PCS for the treatment of severe hypercholesterolemia; ALN-HPN, a pre-clinical development for the treatment of refractory anemia; and ALN-TMP, a pre-clinical development for the treatment of hemoglobinopathies, including beta-thalassemia and sickle cell anemia. The company?s partner-based programs comprise ALN-RSV01, a Phase II clinical trial program for the treatment of respiratory syncytial virus infection; ALN-VSP, a Phase I clinical trial completed program for the treatment of liver cancers; and ALN-HTT, a pre-clinical development for the treatment of Huntington?s disease. It has strategic alliances with Novartis Pharma AG; F. Hoffmann-La Roche Ltd; Takeda Pharmaceutical Company Limited; Isis Pharmaceuticals, Inc.; Medtronic Inc.; Kyowa Hakko Kirin Co., Ltd.; and Cubist Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. Advisors' Opinion: [By Glenn] A relatively new company, Alnylam Pharmaceuticals was founded in 2002, and their shares have shown steady growth since before January 2005. In early January 2012, the shares were worth about $30 and although there were some dips to less than $20 in October/November of this year, they ended up around $25 at the end of December. Alnylam develops RNAi therapies for respiratory diseases and Huntington's, among others and has a broad spectrum of products in its pipeline. This startup also has agreements with number of large companies including Novartis, Biogen an d Roche. 10 Best Biotech Stocks To Buy Right Now: Osiris Therapeutics Inc.(OSIR) Osiris Therapeutics, Inc., a stem cell company, focuses on the development and marketing of therapeutic products to treat various medical conditions in the inflammatory, autoimmune, orthopedic, and cardiovascular areas. It operates in two business segments, Therapeutics and Biosurgery. The Therapeutics segment focuses on developing biologic stem cell drug candidates from a readily available and non-controversial source, adult bone marrow. The Biosurgery segment works to harness the ability of cells and novel constructs to promote the body's natural healing. This segment focuses on developing biologic products for use in surgical procedures. The company?s lead biologic drug candidate is Prochymal, which is in phase 2 and 3 clinical trails for various indications, including acute graft versus host disease (GvHD), Crohn's disease, acute myocardial infarction, type 1 diabetes, pulmonary disease, and gastrointestinal injury resulting from radiation exposure. Its biologic drug candidates also include Chondrogen, a preparation of adult mesenchymal stem cells that is in phase 2 clinical trials for osteoarthritis and cartilage protection. The company has collaboration agreements with Genzyme Corporation for the development and commercialization of Prochymal and Chondrogen in various countries except in the United States and Canada. It also has a partnership with Juvenile Diabetes Research Foundation for the development of Prochymal as a treatment for the preservation of insulin production in patients with newly diagnosed type 1 diabetes mellitus. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland. Advisors' Opinion: [By Skousen] Osiris is one of the nanotechnology stocks that has really shown potential. This stock shows a twelve month ROE of more than eighty five percent, making it one to own for some. Subscribe to: Posts (Atom) Blog Archive ►  2019 (34) ►  March (17) ►  February (17) ►  2018 (16) ►  August (1) ►  July (5) ►  June (2) ►  May (8) ►  2016 (1) ►  December (1) ►  2015 (147) ►  July (9) ►  June (17) ►  May (17) ►  April (15) ►  March (26) ►  February (23) ►  January (40) ►  2014 (400) ►  December (22) ►  November (21) ►  October (51) ►  September (47) ►  August (44) ►  July (61) ►  June (51) ►  May (24) ►  April (25) ►  March (24) ►  February (12) ►  January (18) ▼  2013 (197) ►  December (22) ►  November (23) ►  October (24) ►  September (17) ►  August (20) ▼  July (34) Will LNG Exports Work in the Long Term? Boeing's Fireproof Stock Will Nervous Fed-Watchers Crash the Dow Again? A Fool Looks Back This Week's Top 3 Stocks Top 5 Casino Companies To Buy Right Now FDA Delays Decision (i.e., Reverts to Norm) 10 Best High Tech Stocks To Own For 2014 Top Dividend Stocks To Own Right Now 10 Best Low Price Stocks To Own Right Now Why GM Still Owes Taxpayers Billions Top 10 Energy Companies To Watch For 2014 10 Best Biotech Stocks To Buy Right Now Bladex Keeps Dividend Steady Is the iPhone Finally Apple's Greatest Product? Apple and Tesla: Is the Idea That Crazy? Hot Heal Care Companies To Watch In Right Now Boeing Stock Is Leading the Dow Higher The Top 3 Problems for American Automakers Top Tech Stocks To Watch Right Now Top 10 Bank Companies To Own In Right Now What Does Wall Street See for Packaging Corporatio... Will Japan's Biggest Carrier Ever Cave to the iPhone? Top 10 Financial Stocks To Invest In Right Now 10 Best Prefered Stocks To Watch For 2014 Top Industrial Conglomerate Companies To Invest In... Why TMS International's Earnings May Not Be So Hot 2 Major Pieces of Apple TV News Already Revealed T... Detroit Continues to Dominate Pickup Market Bank of America to AIG: We Have Nothing to Talk About Why BreitBurn Is Poised to Bounce Back Top Quality Companies To Invest In 2014 Top 10 US Companies To Invest In Right Now Top Railroad Companies To Own In Right Now ►  June (35) ►  May (22) About Me Kandy View my complete profile Watermark theme. Powered by Blogger.